Notably, DDB2 overexpression promotes proliferation and colony formation in ERα-positive breast cancer cells 15, and protects triple-negative breast cancer (TNBC) cells from PARP inhibitor (PARPi) therapy by enhancing HR-mediated repair of double-strand breaks 16. Here, DDB2 is linked to breast cancer.